Digital Therapeutics
DynamiCare is in the process of developing prescription digital therapeutics (PDTs) for a wide variety of substance use related conditions. Each product utilizes the Contingency Management Engine™ and core technology stack, tailored to the needs of patients with each condition and guided by the existing evidence base in each area of research. DynamiCare conducts clinical trials on each product with external academic research institutions, and many of the pilot study results have already been published in the peer-reviewed literature.
